Applicant, as named in the Orange Book

Rayner Surgical

Next listed expiry: Omidria on 23 Apr 2034. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Omidria ketorolac tromethamine; phenylephrine hydrochloride	ketorolac tromethamine; phenylephrine hydrochloride	205388	23 Apr 2034	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.